Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas Mach

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|September 6, 2025
Visually assessed ischaemia on cardiac magnetic resonance, but not quantitative perfusion metrics, predicts symptomatic improvement in coronary artery bypassTamim Akbari, Lukas Mach, Daniel J Hammersley, et al.
Biotechnology Journal|January 25, 2022
Designed SARS-CoV-2 receptor binding domain variants form stable monomersMiriam Klausberger, Nikolaus F Kienzl, Gerhard Stadlmayr, et al.
Biotechnology Journal|January 22, 2021
Generation of enzymatically competent SARS-CoV-2 decoy receptor ACE2-Fc in glycoengineered Nicotiana benthamianaAlexandra Castilho, Jennifer Schwestka, Nikolaus F Kienzl, et al.
Frontiers in Plant Science|July 2, 2021
N-Glycosylation of the SARS-CoV-2 Receptor Binding Domain Is Important for Functional Expression in PlantsYun-Ji Shin, Julia König-Beihammer, Ulrike Vavra, et al.
Elife|December 20, 2021
Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptorTümay Capraz, Nikolaus F Kienzl, Elisabeth Laurent, et al.
Scientific Reports|April 2, 2025
An ACE2-Fc decoy produced in glycoengineered plants neutralizes ancestral and newly emerging SARS-CoV-2 variants and demonstrates therapeutic efficacy in hamstersEsther Föderl-Höbenreich, Shiva Izadi, Lara Hofacker, et al.
Scientific Reports|April 12, 2020
Plant-based production of highly potent anti-HIV antibodies with engineered posttranslational modificationsAdvaita Acarya Singh, Ofentse Pooe, Lusisizwe Kwezi, et al.
Open Heart|January 28, 2022
Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathyDaniel J Hammersley, Rachel J Buchan, Amrit S Lota, et al.
Nature Communications|December 24, 2022
Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule levelRong Zhu, Daniel Canena, Mateusz Sikora, et al.
Nature Communications|February 28, 2023
Author Correction: Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule levelRong Zhu, Daniel Canena, Mateusz Sikora, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|September 6, 2025
Visually assessed ischaemia on cardiac magnetic resonance, but not quantitative perfusion metrics, predicts symptomatic improvement in coronary artery bypassTamim Akbari, Lukas Mach, Daniel J Hammersley, et al.
Biotechnology Journal|January 25, 2022
Designed SARS-CoV-2 receptor binding domain variants form stable monomersMiriam Klausberger, Nikolaus F Kienzl, Gerhard Stadlmayr, et al.
Biotechnology Journal|January 22, 2021
Generation of enzymatically competent SARS-CoV-2 decoy receptor ACE2-Fc in glycoengineered Nicotiana benthamianaAlexandra Castilho, Jennifer Schwestka, Nikolaus F Kienzl, et al.
Frontiers in Plant Science|July 2, 2021
N-Glycosylation of the SARS-CoV-2 Receptor Binding Domain Is Important for Functional Expression in PlantsYun-Ji Shin, Julia König-Beihammer, Ulrike Vavra, et al.
Elife|December 20, 2021
Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptorTümay Capraz, Nikolaus F Kienzl, Elisabeth Laurent, et al.
Scientific Reports|April 2, 2025
An ACE2-Fc decoy produced in glycoengineered plants neutralizes ancestral and newly emerging SARS-CoV-2 variants and demonstrates therapeutic efficacy in hamstersEsther Föderl-Höbenreich, Shiva Izadi, Lara Hofacker, et al.
Scientific Reports|April 12, 2020
Plant-based production of highly potent anti-HIV antibodies with engineered posttranslational modificationsAdvaita Acarya Singh, Ofentse Pooe, Lusisizwe Kwezi, et al.
Open Heart|January 28, 2022
Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathyDaniel J Hammersley, Rachel J Buchan, Amrit S Lota, et al.
Nature Communications|December 24, 2022
Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule levelRong Zhu, Daniel Canena, Mateusz Sikora, et al.
Nature Communications|February 28, 2023
Author Correction: Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule levelRong Zhu, Daniel Canena, Mateusz Sikora, et al.
Pageof 10